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INTRODUCTION
It has been reported that in several types of cancers, a decrease in gap junctional intercellular communication (GJIC) is associated with the development of tumors. Gap junctions are intercellular channels formed by proteins termed connexins (Cxs). Gap junctions allow direct communication between cells by allowing the exchange of small molecules (≤ 1 kD) between neighbouring cells (1) . It has been shown that epigenetic carcinogens can promote tumor formation by down-regulating Cxs and consequently GJIC (2) . However, the intracellular signaling pathways implicated in the regulation of Cxs are poorly understood.
Adhering junctions are implicated in cell-cell interactions and in intracellular signalization. They are formed primarily by a large family of single-pass calciumdependent transmembrane proteins termed cadherins (3) . It has been suggested that there exists a functional relationship between adhering and gap junctions, and furthermore, that in certain tissues, adhering junctions are necessary to allow binding of adjacent cellular plasma membranes. This subsequently allows the connexons from each cell to bind and form the intercellular pores of the gap junction. In certain cancers, both adhering and gap junctions are down-regulated, suggesting the existence of common pathways controlling the expression of these two types of intercellular junctions (4, 5) .
The activation of the Integrin-Linked kinase (ILK) pathway has been shown to down-regulate the expression of E-cadherin in intestinal and mammary epithelial cells as well as in human colon carcinoma cell lines (6) . The ILK pathway is a phosphorylation signaling cascade leading to the regulation of genes involved in the control of cellular proliferation, differentiation and cell-cell interactions (7) . The ILK phosphorylation 4 cascade can modulate changes in gene expression via the activation of nuclear transcription factors (6, 7) .
We have demonstrated that exposure to hexachlorobenzene (HCB), an epigenetic environmental carcinogen, resulted in significantly lower levels of both Cx32 and Cx26 as well as GJIC in the livers of female rats sampled 45 days after the administration of HCB (8) . However, Cxs and GJIC in males were unaltered. These changes coincided with a down-regulation of E-cadherin induced by the activation of the ILK signaling pathway (5) . Using both in vivo and in vitro approaches we were able to demonstrate that the ILK pathway was activated in the liver of HCB-treated rat females and that this activation decreased the expression of E-cadherin via inactivation of GSK3β, a downstream target of ILK. However, Cx32 levels were not affected by the inactivation of GSK3β in vitro, although Cx32 mRNA levels were decreased by 50% in HCB-treated cells as compared to the untreated control cells. These results suggested that the regulation Cx32 by HCB occurs either downstream of ILK via a second pathway or through another unidentified signaling pathway parallel to ILK (5) . In HCB-treated female rats, hepatic nuclear Akt protein levels were increased. It has been shown that once activated by phosphorylation, including ILK-induced phosphorylation, Akt phosphorylates different proteins into the cytoplasm and can then translocate into the nucleus where it phosphorylates transcription factors and modulates gene expression (9, 10) .
Since HCB exposure down-regulates hepatic Cx expression in rat both in vivo and in vitro, and since E-cadherin is decreased by HCB-induced ILK pathway activation, it is possible that Cx levels are also modulated by the same pathways, but using an 
MATERIAL AND METHODS

Cell culture conditions
Rat liver cells (MH 1 C 1 ) were purchased from the American Type Culture Collection (ATCC, Manassas, VA). Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS at 37°C with 5% CO 2 .
Transfection and vectors
An ILK expression vector pcDNA3.1/V5-his A was generously provided by Dr. S.
Dedhar (University of British Columbia). A constitutively active myr-Akt1 expression vector pUSEamp(+) was purchased from UpState Biosciences (Upstate Biosciences, Chicago, IL). The Akt-NES-GFP and Akt-WT-GFP expression vectors pEGFP-C1 were generous gifts from Dr. M.D. Ringel (Ohio State University). Cells (95% confluence) were transiently transfected using 40 µg/ml lipofectamine 2000 (InVitrogen Life Technologies) in DMEM without FBS, according manufacturer's instructions. Cells were lysed 24h later and total protein or total RNA was isolated from the lysate. PCL-neo (Promega, Madison, WI) was used as a control vector, and is represented as control group on the graphs. Table 1 summarizes the different vectors used in this study.
Western blot analysis
at Pennsylvania State University on February 23, 2013 http://carcin.oxfordjournals.org/ Downloaded from 6 Cytoplasm and nuclear/membrane proteins were extracted from MH 1 C 1 cells using the NE-PER Cytoplamic and Nuclear Protein extraction kit (Pierce Biotechnology, Rockford, IL, USA). The purity of the nuclear enrichment fraction was determined using albumin as a marker for the cytoplasmic fraction and the transcription factor Sp1 as a marker for the nuclear fraction (Fig. 1) . Overexposed films show less than 6% cross contamination between cytoplasmic and nuclear extracts (data not shown). Protein levels were determined using the Bio-Rad Protein Assay (Bio-Rad Laboratories, Mississauga, ON, Canada). A 50 µg aliquot of total proteins was subjected to SDS-Polyacrylamide gel 
Statistics
Statistical differences between groups were determined by ANOVA followed a posteriori by a Turkey test for multiple comparisons between experimental groups. Each experiment was done in triplicate using 3 to 4 independent samples per group (n=12).
Significance was established at p<0.05. All statistical analyses were done using the SigmaStat computer software (Jandel Scientific Software, San Rafael, CA).
RESULTS
In order to determine if HCB-induced down-regulation of Cx32 observed in vivo
results from the activation of the ILK pathway, MH 1 C 1 , a well-differentiated rat (Fig 2A) , while ILK protein levels were increased 3-fold, as determined by western blot analysis (Fig 2B) .
Our previous studies have shown that HCB can stimulate ILK in rat liver and that this is associated with decreased Cx32 levels. In the present study, we observed a 2-fold decrease in Cx32 mRNA levels in MH 1 C 1 -ILK+ cells relative to controls (Fig 3) . This
indicates that the activation of the ILK pathway results in a down regulation of Cx32 in rat hepatocytes.
Our previous results showed that Akt, a down-stream target of ILK, was increased in hepatic nuclei of HCB-treated females, suggesting its activation by ILK. Akt can be activated by phosphorylation at the plasma membrane by a variety of kinases, including ILK. Western blot analysis indicated that while there was no change in cytoplasmic Akt protein levels in MH 1 C 1 -ILK+ (Fig 4A) , there was a nearly four-fold increase in nuclear/membrane Akt protein levels as compared to untransfected cells (Fig 4B) . Using a phospho-specific anti-Akt antibody, we then showed that there was also a nearly 2-fold increase in phospho-Akt cytoplasmic protein levels in MH 1 C 1 -ILK+ cells as compared to the control (Fig 4C) . Furthermore, there was a four-fold increase of phospho-Akt nuclear/membrane protein levels in MH 1 C 1 -ILK+ cells as compared to the control ( Fig   4D) . These results indicate that the overexpression of ILK and subsequent activation of the ILK pathway in rat hepatocytes can activate the Akt intracellular pathway via an (Fig 5) . In these cells, however, there was also an increase in Akt protein levels in the nuclear/membrane fraction of MH 1 C 1 -Akt+, suggesting the activation and increased expression of Akt (Fig 5) . There was also a substantial increase in active phospho-Akt in both the cytoplasmic and nuclear/membrane Akt can act either at the membrane and cytoplasmic levels, where it can phosphorylate effector proteins, or at the nuclear level, where it can act as a transcription factor or phosphorylate transcription factor(s) (10) . In order to determine if the decrease in Cx32 induced by Akt was due to nuclear translocation of Akt, we tested two other vectors coupled to a green-fluorescent protein (GFP) containing either a wild-type inactive Akt (Akt-WT+) or a mutated nuclear only active form of Akt (Akt-NES+), in which the nuclear-export sequence was modified in order to retain Akt in the nucleus.
Using immunofluorescent microscopy, we first demonstrated that in MH 1 C 1 -Akt-NES+ cells, Akt was present in the nuclei of transfected cells, while in MH 1 C 1 -Akt-WT+, the GFP was distributed throughout the cytoplasm (Fig 7A) . As a result of the low transfection rate observed with the Akt-NES+ vector (approximately 5% of cells), we used flow cytometric approach to analyse the expression of Cx32 only in those cells that expressed the nuclear Akt (Figs 7Bi and 7Bii) . While there were no differences in Cx32 levels between untransfected control cells and cells transfected with the WT inactive vector (MH 1 C 1 -Akt-WT+ cells) (Fig 7Biii) , there was a significant 25% decrease in Cx32 as compared to either MH 1 C 1 -Akt-WT+, or untransfected cells (Fig 7Biii) . These results suggest that nuclear Akt can regulate, at least in part, hepatic Cx32.
DISCUSSION
We have previously shown that HCB-treatment in female rats decreases hepatic Consequently, the objective of this study was to assess whether or not the activation of the ILK pathway is implicated in hepatic Cx32 regulation, and if so, to identify the subpathways implicated in this regulation. In the present study, we have demonstrated that the overexpression of ILK in MH 1 C 1 results in the activation and nuclear translocation of Akt, and that this activation is associated with a decrease in Cx32 mRNA levels.
Combined with our previous results, the present data suggested that the activation of the ILK pathway by HCB results in the down-regulation of both E-cadherin and Cx32, although this appears to be regulated via two different down-stream targets, GSK3β and Akt respectively. 14 ILK is an evolutionarily conserved protein kinase, implicated in both integrin and growth-factor signaling. ILK basal activity is usually low, but can be stimulated by cellcell interactions as well as by certain growth factors, including the epidermal growth factor receptor (EGFR) (12, 13) . Interestingly, it has been shown that HCB can stimulate EGFR (14, 15) . Stimulation of EGFR can activate the ILK pathway and consequently the PI3K pathway which is associated with the recruitment of Akt to the plasma membrane (4, 18) . This is the first study to demonstrate a pathway by which both gap and adhering junction proteins are down-regulated.
Moreover, since both ILK pathway activation and decreased cell-cell interactions are hallmarks of cancer, our results suggest that this mechanism may represent a general mechanism implicated in carcinogenesis.
Little is known about pathways implicated in the regulation of Cxs. Several studies have shown that certain Cxs can be post-trancriptionally regulated by phosphorylation at different steps in the assembly of gap junctions, such as intracellular trafficking, assembly, gating and degradation (19) . Various kinases have been implicated 15 in Cx phosphorylation, including the mitogen-activated protein kinase (MAPK) (20) .
Cx43 has been reported to be regulated by a p38-MAPK in Sertoli cells (21) , as well as liver Cx32 following partial hepatectomy in rat (22) . Glucocorticoids have also been
shown to be important regulators of hepatic GJIC and Cx32 expression (23).
However, while phosphorylation events are important for the post-translational regulation of Cx32, few studies have focused on the involvement of signaling pathways in the transcriptional regulation of Cx32. In our previous studies, HCB exposure resulted in Cx32 down-regulation and increased Akt translocation into the nucleus, suggesting that nuclear Akt might be important in Cx32 regulation, as well as in carcinogenesis (8) (5). In the present study, ILK overexpression induced the nuclear translocation of Akt and a decrease in Cx32 mRNA levels. In order to determine whether or not Akt was responsible for the lower Cx32 levels, we transfected cells with an Akt expression vector.
The resulting decrease in Cx32 mRNA levels indicated that the Akt pathway was at least partly responsible for the lower Cx32 levels. To determine if nuclear Akt was responsible for the lower Cx32 levels, cells were transfected with an expression vector Recent studies have suggested that the nuclear localization of Akt may be important in the process of carcinogenesis. Indeed, it has been shown that Akt is localized into the nucleus of human thyroid tumors, and allows cell migration in a Boyden chamber in vitro (9, 31) . Furthermore, levels of nuclear Akt increase with stages of tumor progression in prostate cancer (32) . Our study suggests a pro carcinogenic role of Akt in modulating a decreased Cx32 expression, an important hallmark of hepatocarcinogenesis.
In summary, we have demonstrated that the overexpression of ILK in rat hepatocytes leads to the activation of Akt and its nuclear translocation. Active Akt is implicated in Cx32 down-regulation via its nuclear effects, although we cannot discount the possibility that cytoplasmic Akt also contributes to lowering levels of Cx32.
Together with our previous studies, these data suggest that the activation of the ILK and lysed 24h later. mRNA was extracted using the phenol-chloroform method and then used for RT-PCR analysis using Cx32 specific primers. Data were standardized for loading using GAPDH mRNA levels. Data are expressed as the mean ± SEM (n = 12, from three independent experiments). ** indicates a significant difference from controls (p<0.01). 
